During the past decade, MZ Badania Slowik Zymla Spolka jawna conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MZ Badania Slowik Zymla Spolka jawna" are "Crohn's Disease" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "MZ Badania Slowik Zymla Spolka jawna" in a lesser frequency.

Most popular intervention types in "MZ Badania Slowik Zymla Spolka jawna" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cobitolimod 250 mg" (1 trials), "Cobitolimod 500 mg" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "MZ Badania Slowik Zymla Spolka jawna" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MZ Badania Slowik Zymla Spolka jawna". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MZ Badania Slowik Zymla Spolka jawna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MZ Badania Slowik Zymla Spolka jawna, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".